Quantum BioPharma (QNTM) said Tuesday that a trial of its dietary supplement, Unbuzzd, confirmed it accelerates alcohol metabolism, speeds the reduction of blood alcohol concentration, and reduces symptoms of intoxication, impairment, and hangover.
The study, which examined Unbuzzd's impact on alcohol intoxication and metabolism, found the results to be statistically significant compared to a placebo.
The effects were noticeable within 30 minutes of consuming the dissolved powder. The supplement was well-tolerated, with no reported adverse effects.
The shares of Quantum BioPharma surged nearly 53% in recent trading.
Price: 4.86, Change: +1.68, Percent Change: +52.83
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.